| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 100.079 | 128.412 | 28.490 | 32.823 |
| Total Income - EUR | - | - | - | - | - | - | 101.843 | 130.569 | 30.847 | 33.046 |
| Total Expenses - EUR | - | - | - | - | - | - | 14.689 | 19.050 | 23.547 | 31.123 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 87.154 | 111.519 | 7.300 | 1.923 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 84.128 | 108.869 | 6.997 | 934 |
| Employees | - | - | - | - | - | - | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Adn Labs S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 19.901 | 19.962 | 48.066 | 42.535 |
| Current Assets | - | - | - | - | - | - | 68.590 | 94.110 | 7.046 | 17.042 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 65.230 | 48.603 | 3.364 | 3.714 |
| Cash | - | - | - | - | - | - | 3.360 | 31.313 | 2.671 | 10.614 |
| Shareholders Funds | - | - | - | - | - | - | 84.168 | 108.918 | 44.388 | 25.954 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 4.476 | 5.297 | 11.600 | 34.618 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6209 - 6209" | |||||||||
| CAEN Financial Year |
6209
|
|||||||||
Comments - Adn Labs S.r.l.